Cryptococcus flips its lid - membrane phospholipid asymmetry modulates antifungal drug resistance and virulence

Erika Shor1, Yina Wang1, David S Perlin2

  • 1Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.

Insights

Infections from human fungi are rising, and drug resistance is growing. Researchers found that blocking lipid flippase, an enzyme in fungal cells, could make antifungal drugs more effective and reduce fungal infections.

Area of Science:

  • Mycology
  • Biochemistry
  • Drug Discovery

Background:

  • Rising prevalence of human fungal infections and increasing antifungal drug resistance pose a significant public health challenge.
  • Antifungal drugs often target the fungal cell membrane, but the role of membrane biology in drug interactions is poorly understood.
  • Phospholipid asymmetry is crucial for membrane function and is maintained by lipid transporters, including lipid flippases.

Purpose of the Study:

  • To investigate the role of lipid flippase in antifungal drug resistance and virulence in the pathogenic fungus *Cryptococcus neoformans*.
  • To explore lipid flippase as a potential novel target for antifungal drug development.

Main Methods:

  • Studied the effects of lipid flippase activity loss on *Cryptococcus neoformans*.
  • Assessed the sensitivity of *Cryptococcus neoformans* to various antifungal drugs.
  • Evaluated the impact of lipid flippase on fungal virulence in murine models.

Main Results:

  • Loss of lipid flippase activity resulted in abnormal phospholipid distribution and impaired vesicular trafficking in *Cryptococcus neoformans*.
  • Reduced lipid flippase activity sensitized cryptococcal cells to multiple classes of antifungal drugs, including echinocandins.
  • Abolished fungal virulence in murine models, indicating lipid flippase's role in pathogenesis.

Conclusions:

  • Lipid flippase activity contributes to antifungal drug resistance and virulence in *Cryptococcus neoformans*.
  • Inhibition of lipid flippase represents a promising strategy for developing new antifungal therapies.
  • Targeting lipid flippase could overcome existing drug resistance mechanisms in fungal infections.

Related Concept Videos

Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...